CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 1, January/February 2021
AFRICA
55
to Tobacco
.
Geneva, Switzerland: World Health Organization, 2012.
17. Institute for Health Metrics and Evaluation. South Africa: Top 10 risks
contributing to DALYs in 2017 and percent change, 2007–2017, all ages,
number. IMHE Measuring what matters.
[Online] 2017. http://www.
healthdata.org/south-africa.18. Shisana O, Labadarios D, Rehle T,
et al
. South African National Health
and Nutrition Examination Survey (SANHANES-1)
.
Cape Town:
HSRC Press, 2013.
19. Reddy SP, James S, Sewpaul R,
et al.
Umthente Uhlaba Usamila – the
3rd South African National Youth Risk Behaviour Survey 2011
.
Cape
Town: South African Medical Research Council, 2013.
20. International Diabetes Federation (IDF).
IDF Diabetes Atlas.
9th edn
.
[Online] 2019.
http://www.diabetesatlas.org/en/resources/.html.21. Rispel LC, Padarath A (eds). South African Health Review 2018.
Durban: Health Systems Trust, 2018.
http://www.hst.org.za/publica-tions/Pages/SAHR2018.
22. Wollum A, Gabert R, McNellan CR,
et al.
Identifying gaps in the
continuum of care for cardiovascular disease and diabetes in two
communities in South Africa: Baseline findings from the HealthRise
project.
PLoS ONE
2018;
13
(3): e0192603.
23. South African Medical Association. SA Heart Guideline: Diet for
prevention of cardiovascular disease. [Online]
https://www.saheart.org/cms-home/category/24.
24. Van Zyl-Smit RN, Allwood B, Stickells D,
et al.
South African tobacco
smoking cessation clinical practice guideline.
S Afr Med J
2013;
103
(11):
869–876.
25. Klug E, Raal FJ, Marais AD,
et al.
South African dyslipidaemia
guideline consensus statement: 2018 update A joint statement from
the South African Heart Association (SA Heart) and the Lipid and
Atherosclerosis Society of Southern Africa (LASSA).
S Afr Med J
2018;
108
(Part 2): 973–1000.
26. The Society for Endocrinology, Metabolism and Diabetes of South
Africa Type 2 Diabetes Guidelines Expert Committee. The 2017
SEMDSA guidelines for the management of type 2 diabetes mellitus.
J
Endocrinol Metab Diabetes S Afr
2017;
21
(1)(Suppl 1): S1–S196.
27. Seedat YK, Rayner BL, Veriava Y; Hypertension guideline working
group. South African hypertension practice guideline 2014.
Cardiovasc
J Afr
2014;
25
: 288–294.
28. Hitzeroth J, Mpe M, Klug E,
et al
. 2020 Heart Failure Society of South
Africa perspective on the 2016 European Society of Cardiology Chronic
Heart Failure Guidelines.
S Afr Med J
2020;
110
(9b): 938–951.
29. Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheu-
matic heart.
Heart
2013;
99
: 1554–1561.
30. National Department of Health.
Standard Treatment Guidelines and
Essential Medicines List for South Africa Primary Healthcare Level.
6th
edn
.
Pretoria: Republic of South Africa, 2018.
31. Karthikeyan G, Zühlke L, Engel M,
et al
. Rationale and design of a
global rheumatic heart disease registry: The REMEDY study.
Am Heart
J
2012;
163
(4): 535–540.
32. Busko M. Valvular atrial fibrillation with HF common, often untreated
in young Africans.
Medscape
07 June 2016.
https://www.medscape.com/viewarticle/864451.
33. Moodley Naidoo R, Timothy GA, Steenkamp L,
et al.
Measuring qual-
ity outcomes across hospital systems: Using a claims data model for
risk adjustment of mortality rates.
S Afr Med J
2019;
109
(5): 299–305.
34. World Health Organization.
WHO Model List of Essential Medicines
.
20th edn. Essential Medicines and Health Products, 2017. https://www.
who.int/medicines/publications/essentialmedicines/en/.
35. Yusuf S, Islam S, Chow CK,
et al
. Use of secondary prevention drugs
for cardiovascular disease in the community in high-income, middle-
income, and low-income countries (the PURE Study): a prospective
epidemiological survey.
Lancet
2011;
378
(9798): 1231–1243.
36. Zühlke L, Karthikeyan G, Engel ME. Clinical outcomes in 3343
children and adults with rheumatic heart disease from 14 low- and
middle-income countries: two-year follow-up of the global rheumatic
heart disease registry (the REMEDY Study).
Circulation
2016;
134
(19):
1456–1466.
37. Statistics South Africa.
South Africa Demographic and Health Survey
2016: Key Indicator Report.
Pretoria: Statistics South Africa, 2017.
38. Department of Health. Strategic plan for the prevention and control of
non-communicable diseases 2013–17. Pretoria: RSA, 2013.
39. Statistics South Africa. Causes of Death. Mortality and causes of death
report. Stats SA, 2018 (ongoing).
http://www.statssa.gov.za/.40. Robertson KA, Volmink JA, Mayosi BM, Writing Committee. 1st All
Africa Workshop on Rheumatic Fever and Rheumatic Heart Disease
Champagne Sports Resort, Drakensberg, South Africa, 15–16 October
2005. Towards a uniform plan for the control of rheumatic fever and
rheumatic heart disease in Africa.
S Afr Med J
2006;
96
(3): 241–245.
41. Tobacco Control Research Group, Department for Health at the
University of Bath. South Africa Country Profile.
Tobacco Tactics.
30
April 2020.
https://tobaccotactics.org/wiki/south-africa-country-profile/.42. Department of Health. Act (12/2012): Draft Control of Tobacco
Products.
Government Gazette
No. 41617
.
Pretoria: Dept of Health, 9
May 2018; 635.
43. World Health Organization. The World Health Organization framework
convention on tobacco control (FCTC). South_Africa_2018_report
.
2018. Available:
http://untobaccocontrol.org/impldb/.44. International Legal Consortium, Global Legal Center. Tobacco Control
Laws. Legislation by Country, South Africa: Tobacco Control Policies.
Campaign for Tobacco-Free Kids, United States, 18 September 2019.
https://www.tobaccocontrollaws.org/legislation/factsheet/policy_status/south-africa.
45. Ortegón M, Lim S, Chisholm D,
et al.
Cost effectiveness of strategies
to combat cardiovascular disease, diabetes, and tobacco use in sub-
Saharan Africa and South East Asia: mathematical modelling study.
Br
Med J
2012;
344
: e607.
46. Pestana JA, Steyn K, Leiman A,
et al
. The direct and indirect costs of
cardiovascular disease in South Africa in 1991.
S Afr Med J
1996;
86
:
679–684.
47. Gaziano TA. Economic burden and the cost-effectiveness of treatment
of cardiovascular diseases in Africa.
Heart
2008;
94
: 140–144.
48. Bangalee V, Suleman F. Has the increase in the availability of generic
drugs lowered the price of cardiovascular drugs in South Africa?
Health
SA Gesondheid
2016;
21
: 60–66.
49. Republic of South Africa. National Health Act, 2003 No. 61 of 2003:
National Health Act, 2004.
Government Gazette
2003;
469
(26595). Cape
Town 23 July 2004.
50. Maphumulo WT, Bhengu BR. Challenges of quality improvement in the
healthcare of South Africa post-apartheid: A critical review.
Curationis
2019;
42
(1): a1901.
51. Republic of South Africa. Constitution of the Republic of South Africa,
Government Gazette
2014. Pretoria, South Africa. 1996.
https://www.gov.za/documents/constitution/constitution-republic-south-africa-1996-1.
52. Stacey N, Summan A, Tugendhaft A,
et al
. Simulating the impact of
excise taxation for disease prevention in low-income and middle-income
countries: an application to South Africa.
Br Med J Glob Health
2018;
3
: e000568.
53. National Department of Health. Primary Care 101 Guideline 2013/14
.
Pretoria: NDoH, 2013/14.
54. Fairall L, Bateman E, Cornick R,
et al
. Innovating to improve primary